AIMS/HYPOTHESIS: We aimed to describe the prevalence of retinopathy in an aged cohort of Icelanders with and without diabetes mellitus. METHODS: The study population consisted of 4,994 persons aged ≥ 67 years, who participated in the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-R). Type 2 diabetes mellitus was defined as HbA(1c) ≥ 6.5% (>48 mmol/mol). Retinopathy was assessed by grading fundus photographs using the modified Airlie House adaptation of the Early Treatment Diabetic Retinopathy Study protocol. Associations between retinopathy and risk factors were estimated using odds ratios obtained from multivariate analyses. RESULTS: The overall prevalence of retinopathy in AGES-R was 12.4%. Diabetes mellitus was present in 516 persons (10.3%), for 512 of whom gradable fundus photos were available, including 138 persons (27.0%, 95% CI 23.2, 31.0) with any retinopathy. Five persons (1.0%, 95% CI 0.3, 2.3) had proliferative retinopathy. Clinically significant macular oedema was present in five persons (1.0%, 95% CI 0.3, 2.3). Independent risk factors for retinopathy in diabetic patients in a multivariate model included HbA(1c), insulin use and use of oral hypoglycaemic agents, the last two being indicators of longer disease duration. In 4478 participants without diabetes mellitus, gradable fundus photos were available for 4,453 participants, with retinopathy present in 476 (10.7%, 95% CI 9.8, 11.6) and clinically significant macular oedema in three persons. Independent risk factors included increasing age and microalbuminuria. CONCLUSIONS/ INTERPRETATION: Over three-quarters (78%) of retinopathy cases were found in persons without diabetes and a strong association between microalbuminuria and non-diabetic retinopathy was found. These results may have implications for patient management of the aged.
AIMS/HYPOTHESIS: We aimed to describe the prevalence of retinopathy in an aged cohort of Icelanders with and without diabetes mellitus. METHODS: The study population consisted of 4,994 persons aged ≥ 67 years, who participated in the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-R). Type 2 diabetes mellitus was defined as HbA(1c) ≥ 6.5% (>48 mmol/mol). Retinopathy was assessed by grading fundus photographs using the modified Airlie House adaptation of the Early Treatment Diabetic Retinopathy Study protocol. Associations between retinopathy and risk factors were estimated using odds ratios obtained from multivariate analyses. RESULTS: The overall prevalence of retinopathy in AGES-R was 12.4%. Diabetes mellitus was present in 516 persons (10.3%), for 512 of whom gradable fundus photos were available, including 138 persons (27.0%, 95% CI 23.2, 31.0) with any retinopathy. Five persons (1.0%, 95% CI 0.3, 2.3) had proliferative retinopathy. Clinically significant macular oedema was present in five persons (1.0%, 95% CI 0.3, 2.3). Independent risk factors for retinopathy in diabeticpatients in a multivariate model included HbA(1c), insulin use and use of oral hypoglycaemic agents, the last two being indicators of longer disease duration. In 4478 participants without diabetes mellitus, gradable fundus photos were available for 4,453 participants, with retinopathy present in 476 (10.7%, 95% CI 9.8, 11.6) and clinically significant macular oedema in three persons. Independent risk factors included increasing age and microalbuminuria. CONCLUSIONS/ INTERPRETATION: Over three-quarters (78%) of retinopathy cases were found in persons without diabetes and a strong association between microalbuminuria and non-diabetic retinopathy was found. These results may have implications for patient management of the aged.
Authors: Chengxuan Qiu; Mary Frances Cotch; Sigurdur Sigurdsson; Ronald Klein; Fridbert Jonasson; Barbara E K Klein; Melissa Garcia; Palmi V Jonsson; Tamara B Harris; Gudny Eiriksdottir; Olafur Kjartansson; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer Journal: Ann Neurol Date: 2009-05 Impact factor: 10.422
Authors: Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati Journal: Lancet Date: 2011-06-24 Impact factor: 79.321
Authors: Petter Bjornstad; David M Maahs; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon Journal: J Diabetes Complications Date: 2014-07-04 Impact factor: 2.852
Authors: Petter Bjornstad; David M Maahs; Lindsey M Duca; Laura Pyle; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon Journal: J Diabetes Complications Date: 2016-02-11 Impact factor: 2.852
Authors: Katharina A Ponto; Jochem Koenig; Tunde Peto; Julia Lamparter; Philipp Raum; Philipp S Wild; Karl J Lackner; Norbert Pfeiffer; Alireza Mirshahi Journal: Diabetologia Date: 2016-06-17 Impact factor: 10.122
Authors: Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong Journal: Nat Rev Dis Primers Date: 2022-03-10 Impact factor: 52.329
Authors: Richard A Jensen; Xueling Sim; Xiaohui Li; Mary Frances Cotch; M Kamran Ikram; Elizabeth G Holliday; Gudny Eiriksdottir; Tamara B Harris; Fridbert Jonasson; Barbara E K Klein; Lenore J Launer; Albert Vernon Smith; Eric Boerwinkle; Ning Cheung; Alex W Hewitt; Gerald Liew; Paul Mitchell; Jie Jin Wang; John Attia; Rodney Scott; Nicole L Glazer; Thomas Lumley; Barbara McKnight; Bruce M Psaty; Kent Taylor; Albert Hofman; Paulus T V M de Jong; Fernando Rivadeneira; Andre G Uitterlinden; Wan-Ting Tay; Yik Ying Teo; Mark Seielstad; Jianjun Liu; Ching-Yu Cheng; Seang-Mei Saw; Tin Aung; Santhi K Ganesh; Christopher J O'Donnell; Mike A Nalls; Kerri L Wiggins; Jane Z Kuo; Cornelia M van Duijn; Vilmundur Gudnason; Ronald Klein; David S Siscovick; Jerome I Rotter; E Shong Tai; Johannes Vingerling; Tien Y Wong Journal: PLoS One Date: 2013-02-05 Impact factor: 3.240
Authors: Lucia Sobrin; Gayatri Susarla; Lynn Stanwyck; John M Rouhana; Ashley Li; Samuela Pollack; Robert P Igo; Richard A Jensen; Xiaohui Li; Maggie C Y Ng; Albert V Smith; Jane Z Kuo; Kent D Taylor; Barry I Freedman; Donald W Bowden; Alan Penman; Ching J Chen; Jamie E Craig; Sharon G Adler; Emily Y Chew; Mary Frances Cotch; Brian Yaspan; Paul Mitchell; Jie Jin Wang; Barbara E K Klein; Tien Y Wong; Jerome I Rotter; Kathyrn P Burdon; Sudha K Iyengar; Ayellet V Segrè Journal: Am J Ophthalmol Date: 2021-06-21 Impact factor: 5.488
Authors: Samuela Pollack; Robert P Igo; Richard A Jensen; Mark Christiansen; Xiaohui Li; Ching-Yu Cheng; Maggie C Y Ng; Albert V Smith; Elizabeth J Rossin; Ayellet V Segrè; Samaneh Davoudi; Gavin S Tan; Yii-Der Ida Chen; Jane Z Kuo; Latchezar M Dimitrov; Lynn K Stanwyck; Weihua Meng; S Mohsen Hosseini; Minako Imamura; Darryl Nousome; Jihye Kim; Yang Hai; Yucheng Jia; Jeeyun Ahn; Aaron Leong; Kaanan Shah; Kyu Hyung Park; Xiuqing Guo; Eli Ipp; Kent D Taylor; Sharon G Adler; John R Sedor; Barry I Freedman; I-Te Lee; Wayne H-H Sheu; Michiaki Kubo; Atsushi Takahashi; Samy Hadjadj; Michel Marre; David-Alexandre Tregouet; Roberta Mckean-Cowdin; Rohit Varma; Mark I McCarthy; Leif Groop; Emma Ahlqvist; Valeriya Lyssenko; Elisabet Agardh; Andrew Morris; Alex S F Doney; Helen M Colhoun; Iiro Toppila; Niina Sandholm; Per-Henrik Groop; Shiro Maeda; Craig L Hanis; Alan Penman; Ching J Chen; Heather Hancock; Paul Mitchell; Jamie E Craig; Emily Y Chew; Andrew D Paterson; Michael A Grassi; Colin Palmer; Donald W Bowden; Brian L Yaspan; David Siscovick; Mary Frances Cotch; Jie Jin Wang; Kathryn P Burdon; Tien Y Wong; Barbara E K Klein; Ronald Klein; Jerome I Rotter; Sudha K Iyengar; Alkes L Price; Lucia Sobrin Journal: Diabetes Date: 2018-11-28 Impact factor: 9.337
Authors: Maria Papaspurou; Vasiliki C Laschou; Paraskevi Partsiopoulou; Evangelos C Fradelos; Christos F Kleisiaris; Malamati A Kalota; Anna Neroliatsiou; Ioanna V Papathanasiou Journal: Med Arch Date: 2015-06-10